SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-16-009549
Filing Date
2016-01-05
Accepted
2016-01-05 07:09:53
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 a2227008z424b5.htm 424B5 310801
2 G805648.JPG g805648.jpg GRAPHIC 11910
3 G322841.JPG g322841.jpg GRAPHIC 14387
4 G436110.JPG g436110.jpg GRAPHIC 59752
5 G867321.JPG g867321.jpg GRAPHIC 42908
6 G798345.JPG g798345.jpg GRAPHIC 39962
  Complete submission text file 0001047469-16-009549.txt   545221
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-204284 | Film No.: 161320087
SIC: 2834 Pharmaceutical Preparations